HSP90 Promotes Cell Glycolysis, Proliferation and Inhibits Apoptosis

HSP90 Promotes Cell Glycolysis, Proliferation and Inhibits Apoptosis

Xu et al. Molecular Cancer (2017) 16:178 DOI 10.1186/s12943-017-0748-y RESEARCH Open Access HSP90 promotes cell glycolysis, proliferation and inhibits apoptosis by regulating PKM2 abundance via Thr-328 phosphorylation in hepatocellular carcinoma Qiuran Xu1†, Jianfeng Tu2†, Changwei Dou3†, Jun Zhang4†, Liu Yang1, Xin Liu5, Kefeng Lei6, Zhikui Liu3, Yufeng Wang3, Lijie Li7, Hangxing Bao8, Jiahui Wang9 and Kangsheng Tu3* Abstract Background: Heat shock protein 90 (HSP90) functions as a well-known onco-protein to regulate protein conformation, stability and degradation. Pyruvate kinase M2 (PKM2), a critical regulator of the metabolism, growth and metastasis of cancer cells, has been confirmed to be overexpressed in various human cancer including hepatocellular carcinoma (HCC). However, the molecular mechanisms underlying the oncogenic functions of HSP90 and PKM2 overexpression in HCC remain unknown. Methods: The expression of HSP90 and PKM2 in HCC specimens and cells were detected by immunoblotting and immunostaining. The interaction between HSP90 and PKM2 was confirmed by tandem affinity purification, co- immunoprecipitation and Glutathione S transferase (GST)-pulldown assay. Results: In this study, we found that HSP90 could bind to PKM2 and subsequently increased PKM2 abundance in HCC cells. Immunohistochemistry (IHC) staining showed that HSP90 level was positively correlated with PKM2 level in HCC tissues. Mechanistically, HSP90 was found to increase the phosphorylation of PKM2 at Thr-328. Protein kinase glycogen synthase kinase-3β (GSK-3β) formed a protein complex with HSP90 and PKM2, and directly mediated Thr-328 phosphorylation of PKM2 induced by HSP90. Thr-328 phosphorylation was critical for maintaining PKM2 stability and its biological functions in regulating glycolysis, mitochondria respiration, proliferation and apoptosis. Functionally, we found that HSP90 promoted the glycolysis and proliferation and inhibited apoptosis of HCC cells in a PKM2 dependent manner. In vivo experiments disclosed that PKM2 was required for the promoting effects of HSP90 on the growth of HCC cells in mice. Furthermore, we demonstrated that positive expression of HSP90 and PKM2 was correlated with poor clinicopathological features including high alpha fetoprotein (AFP) level, large tumor size, portal vein tumor thrombus (PVTT)andadvancedtumor-node-metastasis(TNM)stage.Furthermore, we demonstrated that positive expression of HSP90 and PKM2, and a combination of these proteins could strongly predict the poor prognosis of HCC patients. Conclusions: We suggest that HSP90 potentiates the glycolysis and proliferation, reduces the apoptosis and thus enhances the growth of HCC cells through PKM2. Keywords: Hepatocellular carcinoma, HSP90, PKM2, Glycolysis, Growth * Correspondence: [email protected] †Equal contributors 3Department of Hepatobiliary Surgery, the First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, Shaanxi 710061, China Full list of author information is available at the end of the article © The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. Xu et al. Molecular Cancer (2017) 16:178 Page 2 of 16 Background clinicopathological features and poor prognosis of HCC pa- Hepatocellular carcinoma (HCC), one of the most common tients [17]. However, the molecular mechanisms underlying malignant tumors worldwide, ranks as the third leading the oncogenic functions of HSP90 in HCC progression re- cause of cancer-related deaths [1]. Currently, surgical resec- main unknown. tion and liver transplantation are curative options for HCC In this study, we demonstrated for the first time that patients [2]. Although the remarkable advance has been HSP90 was a novel binding partner of PKM2 and in- achieved in treatment of HCC, the long term prognosis of creased PKM2 protein abundance in HCC by enhancing HCC patients remains poor [3]. The critical reasons for the the protein stability and reducing the proteasomal degrad- unsatisfactory prognosis of HCC patients include malignant ation of PKM2. Overexpression of HSP90 led to the phos- growth and systemic metastasis of HCC. However, the phorylation of PKM2 at Thr-328 while HSP90 knockdown underlying mechanisms responsible for the growth and me- reduced PKM2 Thr-328 phosphorylation. GSK-3β, a ca- tastasis of HCC remain largely unknown. nonical protein kinase, formed a protein complex with Pyruvate kinase (PK), which is a rate-limiting enzyme of HSP90 and PKM2, and mediated Thr-328 phosphoryl- cellular glycolysis, exists in 4 isoforms (M1, M2, L, and R) ation of PKM2 induced by HSP90. Thr-328 phosphoryl- [4]. Among these four isoforms, PKM2 is predominantly ation was critical for the protein stability and biological expressed in the fetus and is replaced by PKM1 during de- functions of PKM2. Functionally, we found that HSP90 velopment [5]. However, the abundance of PKM2 is dra- promoted glycolysis and proliferation, and inhibited apop- matically increased in tumor cells, indicating an important tosis of HCC cells through PKM2. Moreover, PKM2 was role of PKM2 in cancer cells [6]. PKM2 has been found to required for the promoting effect of HSP90 on the growth be overexpressed in various cancers and acts as a critical of HCC cells in vivo. Lastly, we revealed that HSP90 ex- regulator of cancer cell metabolism [7]. PKM2 leads to in- pression was positively correlated with PKM2 expression creased glucose uptake and lactate production and de- in HCC tissues. In all, this study demonstrated for the first creased O2 consumption of cancer cells. PKM2 also time that HSP90, a newly identified binding partner of promotes the anabolic metabolism of glucose for macro- PKM2, promoted the growth of HCC by regulating Thr- molecular biosynthesis and enhances the growth of cancer 328 phosphorylation and PKM2 abundance. cells [4]. Additionally, PKM2 acts as a transcriptional coac- tivator to promote the gene transcription in cancer cells [8, 9]. Previous study in ovarian cancer cells found that. CHIP Methods (carboxyl terminus of Hsc70-interacting protein), a U-box Clinical samples E3 ligase, was found to interact with PKM2 and regulated One hundred HCC tissues and adjacent non-tumor tis- the ubiquitination and stability of PKM2 and metabolism sues were collected in the Department of Hepatobiliary [10]. Ubiquitination of PKM2 mediated by Parkin, another Surgery, the First Affiliated Hospital of Xi’an Jiaotong Uni- ubiquitin E3 ligase, led to decreased enzymatic activity of versity. All patients did not receive any radiotherapy, PKM2 [11]. Moreover, Ubiquitin-specific protease 20, one chemotherapy or radiofrequency ablation before surgical of deubiquitinating enzymes (DUBs), was found to bind resection. The clinicopathological and demographic infor- with PKM2 and regulated PKM2 ubiquitination [12]. mation of the patients was described in Table 1. Patients’ Therefore, the interaction between PKM2 and its binding tissues were collected and stored in paraformaldehyde for proteins could alter the ubiquitination status of PKM2, and immunohistochemistry (IHC). was critical for maintaining the expression level and func- tions of PKM2. Our previous study found that the expres- sion of PKM2 was significantly increased in HCC [13]. Cell culture However, the underlying mechanisms responsible for the Hep3B, Huh7, 293 T and HEK-293 cells were bought aberrant expression of PKM2 in HCC remain unknown. from the Institute of Biochemistry and Cell Biology, The heat shock proteins (HSPs), a group of highly con- Chinese Academy of Sciences (Shanghai, China). DMEM served molecular chaperones, play various roles in cell (Dulbecco’s modified Eagle’s medium; Gibco, Grand Is- function including protein folding, the assembly of protein land, NY, USA) supplemented with 10% fetal bovine complex and protein degradation [14]. HSP90, a member serum (FBS; Gibco), penicillin (100 units/ml, Sigma, St. of HSPs family, has been found to play critical roles in regu- Louis, MO, USA) and streptomycin (100 μg/ml, Sigma) lating the proliferation, apoptosis and metastasis of tumor was used for cell culture. All these cells were kept in a cells [15]. HSP90 can regulate the conformation, stability humidified 5% CO2 incubator at 37 °C. For 17-AAG and function of various oncogenic proteins to participate in (Sigma) and 17-DMAG (Sigma) treatment, the cells were the development and progression of human cancer [16]. cultured in serum-free DMEM for 12 h, and then were Our previous studies showed that HSP90 was overex- cultured in serum-free DMEM containing 17-AAG or pressed in HCC and was associated with unfavorable 17-DMAG for 24 h. Xu et al. Molecular Cancer (2017) 16:178 Page 3 of 16 Table 1 Clinical correlation of HSP90 and PKM2 expression in HCC Clinicopathological n HSP90 P value PKM2 P value Features Positive Negative Positive Negative Age (y) <50 32 20 12 0.086 18 14 0.669 ≥50 68 29 39 34 34 Sex Male 65 31 34 0.834 35 30 0.677 Female 35 18 17 17 18 HBV Absent 31 17 14 0.518 18 13 0.517 Present 69 32 37 34 35 Cirrhosis Absent 21 12 9 0.466 9 12 0.462 Present 79 37 42 43 36 AFP level (ng/mL) <400 22 13 9 0.338 6 16 0.015 ≥400 78 36 42 46 32 Tumor size <5 55 18 37 0.006 21 34 0.003 (cm) ≥5453114 3114 PVTT Absent 36 10 26 0.002 11 25 0.002 Present 64 39 25 41 23 TNM stage I + II 59 20 39 0.005 24 35 0.008 III+IV412912 2813 Significant values (P<0.05) are in italic and bold Cell transfection and retroviral transduction IHC staining One group of Control shRNA (sc-108,060) and HSP90 IHC was performed on 5-μm-thick sections from shRNA (sc-35,608) were obtained from Santa Cruz formalin-fixed, paraffin-embedded tissue samples applied Biotechnology (Santa Cruz, CA, USA).

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    16 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us